The GOLD COPD Update 2026 provides updated guidance on case-finding, disease activity, exacerbation management.

According to Dr Shibu Vijayan, Chief Medical Officer, Global Health, Qure.ai, the impact of early COPD diagnosis is profound.

Lung diseases are a major global health concern. Many conditions begin silently with subtle signs. Early detection of ...

Non-Cystic Fibrosis Bronchiectasis Treatment Market to Reach USD 3.5 Bn by 2035 at 5.8% CAGR, Driven by rising disease burden ...

Along with these ailments, however, there are a handful of other health afflictions to look out for, say doctors – ones that are particularly likely to take hold in low temperatures and already dry ...

Laryngoscopes held the largest market share in 2024, contributing 32% (USD 794 million). Increasing adoption of video laryngoscopes, higher success rates in difficult airways, and improved safety ...

A Chinese Phase IIb trial of the mAb has already started, with Mabwell also hoping to initiate a Phase IIa trial in the US.

Tezepelumab reduced exacerbations across all seasons in severe uncontrolled asthma, even among patients with perennial and seasonal allergies.

The 2026 version of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy report has been published. Key ...

Zein became aware of alcohol’s impact on COPD a few years ago. In a paper published in 2021, Zein and colleagues found that ...

She told us her life changed when she sought treatment at Christ Hospital and met Dr. Duane Allen, a pulmonary and critical ...

If you are a COPD patient you may be at risk of flare-ups in the colder months. Check out the expert-approved tips which ...